# F17464 in Acute Schizophrenia Trial

> **NCT02151656** · PHASE2 · COMPLETED · sponsor: **Pierre Fabre Medicament** · enrollment: 158 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** F17464
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02151656
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2016-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02151656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02151656, "F17464 in Acute Schizophrenia Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02151656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*